Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic
ChemMedChem · 2025
DOI: 10.1002/cmdc.202401005 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Maria Pia Lenza und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences and Task Force for Microbiome Studies, University of Naples Federico II, Via Cinthia 4, 80126, Naples, Italy. Hauptthemen laut MEDLINE: Galectin 3, Organoselenium Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Universities and Research, PRIN MUR 2022.
Abstract (Originalsprache)
Chimera‐type galectin‐3 (Gal‐3) is a β‐galactoside‐binding protein containing a single conserved carbohydrate‐recognition domain, crucial in fibrosis and carcinogenesis. Selenium‐based Gal‐3 inhibitors have emerged as promising therapeutic agents, particularly for treating neoplastic diseases. Among them, a seleno‐digalactoside (SeDG) substituted with a benzyl group at position 3 of both saccharide residues (benzyl 3,3′‐seleno‐digalactoside, SeDG‐Bn), attracted considerable attention for its selectivity and potent inhibitory efficacy against Gal‐3. NMR spectroscopy and molecular dynamics simulations were combined to investigate the binding of SeDG‐Bn to Gal‐3 at the molecular level. This approach revealed the recognized epitope, the binding mode within Gal‐3 binding pocket and enabled the generation of a 3D model of the complex. Our findings show that the presence of a single benzyl group establishes hydrophobic contacts with amino acids in Gal‐3 β‐sheets S2 and S3, crucially enhancing the binding affinity compared to unmodified SeDG. The digalactose backbone orientation in Gal‐3 binding site is partially modified by the benzyl group with respect to complexes with lactosamine and SeDG. These results provide valuable insights into the design of more potent and selective inhibitors for Gal‐3, potentially contributing to new therapeutic strategies for conditions such as cancer and fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences and Task Force for Microbiome Studies, University of Naples Federico II, Via Cinthia 4, 80126, Naples, Italy.
- Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 49, 80131, Napoli, Italy.
- CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore, 486, 80131, Napoli NA.
- Institute of Biostructures and Bioimaging, National Research Council (CNR), Via P. Castellino 111, 80131, Naples, Italy.
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "Luigi Vanvitelli", Via Vivaldi, 43, Caserta, Italy.
- Department of Physics "Ettore Pancini", University of Naples Federico II, Via Cinthia 4, 80126, Naples, Italy.
ORCID-Profile: Alba Silipo
Förderung
- Ministry of Education
- Universities and Research
- PRIN MUR 2022
- PRIN MUR PNRR 2022
- Italian MUR
- European Union's Horizon 2020
- European Research Council
- Ministry of Higher Education and Scientific Research
Zitieren
APA
Pia Lenza, M., Di Carluccio, C., Nieto-Fabregat, F., Pirone, L., Russo, R., Di Gaetano, S., Capasso, D., Stornaiuolo, A., Iadonisi, A., Saviano, M., Marchetti, R., Pedone, E., & Silipo, A. (2025). Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic. ChemMedChem. https://doi.org/10.1002/cmdc.202401005
Vancouver
Pia Lenza M, Di Carluccio C, Nieto-Fabregat F, Pirone L, Russo R, Di Gaetano S, et al. Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic. ChemMedChem. 2025. doi:10.1002/cmdc.202401005
BibTeX
@article{PiaLenza2025,
author = {Pia Lenza, Maria and Di Carluccio, Cristina and Nieto-Fabregat, Ferran and Pirone, Luciano and Russo, Rita and Di Gaetano, Sonia and Capasso, Domenica and Stornaiuolo, Alessia and Iadonisi, Alfonso and Saviano, Michele and Marchetti, Roberta and Pedone, Emilia and Silipo, Alba},
title = {Structural Insights Into Galectin‐3 Recognition of a Selenoglycomimetic},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202401005}
}
EUVIMED